Ibtasam Wajid | Medicine | Best Researcher Award

Published on by Best Achievements

Mr. Ibtasam Wajid | Medicine | Best Researcher Award

Shenzhen University China | Pakistan

Ibtasam Wajid is a dedicated researcher currently pursuing a PhD in Biomedical Engineering at Shenzhen University, China, with a strong academic foundation in Health Informatics (MS, COMSATS University Islamabad) and Biochemistry (BS, Islamia University of Bahawalpur). Working under the supervision of Prof. Dr. Nadeem Javaid at Comsens Lab, COMSATS University, Islamabad, Ibtasam’s research focuses on the integration of machine learning and deep learning techniques in healthcare, particularly for cardiovascular disease prediction and medical data analysis. His expertise encompasses data science, biomedical signal processing, and artificial intelligence applications in clinical decision-making. He has contributed to publications and collaborative projects, with an h-index of 2, 4 published documents, and over 35 citations on Google Scholar, reflecting his growing influence in computational health research. His technical proficiency includes Python, R-Studio, LaTeX, SPSS, and QGIS, along with hands-on laboratory skills in molecular biology and medical imaging. Beyond research, he has organized workshops and mentored undergraduate students in innovative data-driven healthcare projects. His commitment to scientific advancement and multidisciplinary collaboration positions him as a promising researcher contributing to the future of intelligent healthcare systems.

Profile: Scopus | Google Scholar 

Featured Publications

shaq, S., Afzal, S., Usmani, S. A., Wajid, I., Aziz, A., Tahir, R., Ahmad, A., & Ullah, A. (2025). Inflammatory cell death and leukemia treatment. Critical Reviews in Oncology/Hematology, 104909.

 

Olga Golubnitschaja | Medicine | Best Researcher Award

Published on by Best Achievements

Prof. Dr. Olga Golubnitschaja | Medicine | Best Researcher Award

University Hospital | Friedrich-Wilhelms University of Bonn | Germany

Prof. Dr. Olga Golubnitschaja is an internationally recognized pioneer and world-leading authority in Predictive, Preventive, and Personalised Medicine (3PM), serving as the head of the world’s first 3PM initiative at the University Hospital of Bonn, Germany. She is the President of the European Association for Predictive, Preventive and Personalised Medicine (EPMA, Brussels), connecting experts across 56 countries, and Editor-in-Chief of the EPMA Journal and the SpringerNature book series “Advances in Predictive, Preventive & Personalised Medicine.” With an academic background in biomedicine and decades of leadership in shaping international biomedical research, Prof. Golubnitschaja has made transformative contributions to predictive diagnostics, targeted prevention, personalised treatments, and the integration of artificial intelligence in healthcare. She has authored over 400 peer-reviewed publications, with more than 200 indexed in PubMed, and published extensively in leading journals across disciplines such as oncology, cardiology, neurology, ophthalmology, endocrinology, and molecular medicine. Her cumulative impact is reflected in outstanding scientometric indicators, including an h-index of 46, 208 published documents, and 6,612 citations recorded by Scopus, in addition to a cumulative h-index of 70 on Google Scholar with more than 1,200 citations. These achievements highlight her exceptional influence in advancing innovative medical strategies, patient stratification, and cost-effective healthcare tailored to individual patient needs

Profiles: Scopus | Orcid | Google Scholar | Staff Page

Featured Publications

    • Golubnitschaja, O. (2022). Flavonoids exert potential in the management of hypertensive disorders in pregnancy. Pregnancy Hypertension, 29, 178–180.

    • Golubnitschaja, O. (2022). Anti-prostate cancer protection and therapy in the framework of predictive, preventive and personalised medicine — comprehensive effects of phytochemicals in primary, secondary and tertiary care. EPMA Journal, 13, 267–280.

    • Golubnitschaja, O. (2022). Anti-breast cancer effects of phytochemicals: Primary, secondary, and tertiary care. EPMA Journal, 13, 249–266.

    • Golubnitschaja, O. (2022). Mitochondrial health quality control: Measurements and interpretation in the framework of predictive, preventive, and personalized medicine. EPMA Journal, 13, 281–297.

    • Golubnitschaja, O. (2022). Prostate cancer treatment costs increase more rapidly than for any other cancer—How to reverse the trend? EPMA Journal, 13, 119–122.